Pages that link to "Q33594252"
The following pages link to Interactions of protein antigens with antibodies (Q33594252):
Displaying 50 items.
- Localization and Characterization of Flavivirus Envelope Glycoprotein Cross-Reactive Epitopes (Q24289053) (← links)
- Epitome: database of structure-inferred antigenic epitopes (Q24538505) (← links)
- Structural and functional insights into the B30.2/SPRY domain. (Q24541987) (← links)
- Structural models for carcinoembryonic antigen and its complex with the single-chain Fv antibody molecule MFE23 (Q27624926) (← links)
- Mutual conformational adaptations in antigen and antibody upon complex formation between an Fab and HIV-1 capsid protein p24 (Q27628285) (← links)
- The molecular basis of FHA domain:phosphopeptide binding specificity and implications for phospho-dependent signaling mechanisms (Q27628846) (← links)
- Structural evidence for entropic contribution of salt bridge formation to a protein antigen-antibody interaction: the case of hen lysozyme-HyHEL-10 Fv complex (Q27631152) (← links)
- Structure of CD40 ligand in complex with the Fab fragment of a neutralizing humanized antibody (Q27634524) (← links)
- The role of hydrogen bonding via interfacial water molecules in antigen-antibody complexation. The HyHEL-10-HEL interaction (Q27639993) (← links)
- Crystal structure of the alpha1beta1 integrin I domain in complex with an antibody Fab fragment (Q27640843) (← links)
- Structural consequences of target epitope-directed functional alteration of an antibody. The case of anti-hen lysozyme antibody, HyHEL-10 (Q27641047) (← links)
- The crystal structure of human angiogenin in complex with an antitumor neutralizing antibody (Q27641626) (← links)
- Structural consequences of mutations in interfacial Tyr residues of a protein antigen-antibody complex. The case of HyHEL-10-HEL (Q27643291) (← links)
- Thermodynamic consequences of mutations in vernier zone residues of a humanized anti-human epidermal growth factor receptor murine antibody, 528 (Q27648835) (← links)
- Synthetic antibodies for specific recognition and crystallization of structured RNA (Q27649448) (← links)
- Crystal structure of unliganded influenza B virus hemagglutinin (Q27649507) (← links)
- Critical contribution of VH-VL interaction to reshaping of an antibody: The case of humanization of anti-lysozyme antibody, HyHEL-10 (Q27649729) (← links)
- A heterospecific leucine zipper tetramer (Q27652247) (← links)
- Efalizumab binding to the LFA-1 L I domain blocks ICAM-1 binding via steric hindrance (Q27654007) (← links)
- Crystal Structure of the Engineered Neutralizing Antibody M18 Complexed to Domain 4 of the Anthrax Protective Antigen (Q27654632) (← links)
- Deconstructing the Antiviral Neutralizing-Antibody Response: Implications for Vaccine Development and Immunity (Q27654848) (← links)
- Contribution of Asparagine Residues to the Stabilization of a Proteinaceous Antigen-Antibody Complex, HyHEL-10-Hen Egg White Lysozyme (Q27658806) (← links)
- Antibody recognition of a unique tumor-specific glycopeptide antigen (Q27661722) (← links)
- Structural basis of immunosuppression by the therapeutic antibody daclizumab (Q27664283) (← links)
- Specific Fluorine Labeling of the HyHEL10 Antibody Affects Antigen Binding and Dynamics (Q27670657) (← links)
- Towards a Structural Comprehension of Bacterial Type VI Secretion Systems: Characterization of the TssJ-TssM Complex of an Escherichia coli Pathovar (Q27675723) (← links)
- Defining a protective epitope on factor H binding protein, a key meningococcal virulence factor and vaccine antigen (Q27676318) (← links)
- T Cell Receptors are Structures Capable of Initiating Signaling in the Absence of Large Conformational Rearrangements (Q27676807) (← links)
- Crystal Structure of Human TWEAK in Complex with the Fab Fragment of a Neutralizing Antibody Reveals Insights into Receptor Binding (Q27678102) (← links)
- Conformational Shift of a Major Poliovirus Antigen Confirmed by Immuno-Cryogenic Electron Microscopy (Q27678634) (← links)
- Structural Evaluation of EGFR Inhibition Mechanisms for Nanobodies/VHH Domains (Q27678732) (← links)
- Computational Design of a Protein-Based Enzyme Inhibitor (Q27678929) (← links)
- Crystal structure of a camel single-domain VH antibody fragment in complex with lysozyme (Q27733338) (← links)
- Crystal structure of Lyme disease antigen outer surface protein A complexed with an Fab (Q27735918) (← links)
- Structure of human IgM rheumatoid factor Fab bound to its autoantigen IgG Fc reveals a novel topology of antibody-antigen interaction (Q27737231) (← links)
- The three-dimensional structure of a T-cell antigen receptor V alpha V beta heterodimer reveals a novel arrangement of the V beta domain (Q27741302) (← links)
- A novel DNA-binding motif in MarA: the first structure for an AraC family transcriptional activator (Q27765261) (← links)
- VEGF and the Fab fragment of a humanized neutralizing antibody: crystal structure of the complex at 2.4 A resolution and mutational analysis of the interface (Q27765383) (← links)
- Crystal structure of Taq DNA polymerase in complex with an inhibitory Fab: the Fab is directed against an intermediate in the helix-coil dynamics of the enzyme (Q27765686) (← links)
- Principles of protein-protein interactions (Q27860855) (← links)
- The atomic structure of protein-protein recognition sites (Q27861113) (← links)
- Homologous segments in three subunits of the guanine nucleotide exchange factor eIF2B mediate translational regulation by phosphorylation of eIF2. (Q27938220) (← links)
- Selection and identification of single domain antibody fragments from camel heavy-chain antibodies (Q28250517) (← links)
- Mapping the charged residues in the second immunoglobulin-like domain of the vascular endothelial growth factor/placenta growth factor receptor Flt-1 required for binding and structural stability (Q28260756) (← links)
- Crystal structure of a soluble CD28-Fab complex (Q28306324) (← links)
- Antibody complementarity-determining regions (CDRs) can display differential antimicrobial, antiviral and antitumor activities (Q28472892) (← links)
- Structural basis for cancer immunotherapy by the first-in-class checkpoint inhibitor ipilimumab (Q30274619) (← links)
- Insights into protein-protein binding by binding free energy calculation and free energy decomposition for the Ras-Raf and Ras-RalGDS complexes. (Q30333153) (← links)
- Alterations in immunodominance of Streptococcus mutans AgI/II: lessons learned from immunomodulatory antibodies (Q30355763) (← links)
- Thermodynamics of antibody-antigen interaction revealed by mutation analysis of antibody variable regions. (Q30374518) (← links)